Farhad Najmeddin
- Infectious Diseases top 10%
- Pharmacology top 10%
- Epidemiology
- Neurology
- Nephrology top 10%
- Co-authors
- Mojtaba MojtahedzadehAtabak NajafiArezoo AhmadiHamidreza SharifniaMohammad Reza RouiniHaleh AshrafAdeleh SahebnasaghAbbas Soleimani
- Topics
- Sepsis Diagnosis and Treatment (13 papers)COVID-19 Clinical Research Studies (11 papers)Antibiotics Pharmacokinetics and Efficacy (11 papers)
- Cited by
- Applied Microbiology and BiotechnologyInfectious DiseasesCritical Care and Intensive Care Medicine
- Journals
- SHILAP Revista de lepidopterologíaCurrent Medicinal ChemistryAmerican Journal of Hypertension
In The Last Decade
Farhad Najmeddin
42 papers receiving 356 citations
Peers
Comparison fields: 5 of 75
- Infectious Diseases 122
- Pharmacology 92
- Epidemiology 88
- Neurology 58
- Nephrology 41
Countries citing papers authored by Farhad Najmeddin
This map shows the geographic impact of Farhad Najmeddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Najmeddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Najmeddin more than expected).
Fields of papers citing papers by Farhad Najmeddin
This network shows the impact of papers produced by Farhad Najmeddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Najmeddin. The network helps show where Farhad Najmeddin may publish in the future.
Co-authorship network of co-authors of Farhad Najmeddin
This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Najmeddin. A scholar is included among the top collaborators of Farhad Najmeddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Najmeddin. Farhad Najmeddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 9 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 10 | |
| 12 | 5 | |
| 13 | 34 | |
| 14 | 21 | |
| 15 | 8 | |
| 16 | 7 | |
| 17 | 22 | |
| 18 | Therapeutic Drug Monitoring of Vancomycin Following Critical Care Illnesses: Peak Concentration Determination Maybe Critical | 2 |
| 19 | Pharmacist-Led Medication Review: Supports for New Role of Pharmacists | 5 |
| 20 | Administration of higher doses of Amikacin in early stages of sepsis in critically ill patients | 6 |
About Farhad Najmeddin
Farhad Najmeddin is a scholar working on Geriatrics and Gerontology, Nephrology and Critical Care and Intensive Care Medicine, having authored 45 papers that have together received 363 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (13 papers), COVID-19 Clinical Research Studies (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (21 citations), Infectious Diseases (122 citations) and Critical Care and Intensive Care Medicine (33 citations). Farhad Najmeddin has collaborated with scholars based in Iran, Australia and Hungary. Frequent co-authors include Mojtaba Mojtahedzadeh, Atabak Najafi, Arezoo Ahmadi, Hamidreza Sharifnia, Mohammad Reza Rouini, Haleh Ashraf, Adeleh Sahebnasagh, Abbas Soleimani, Maryam Bahreini and Sarah Mousavi. Their work appears in journals such as SHILAP Revista de lepidopterología, Current Medicinal Chemistry and American Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.